Long-term Investment Secured - Swiss Foundation Supports Innovative Concept for Patients With Diabetes

August 26th, 2009 LONDON - A new research study carried out by The Research Partnership reveals that living with diabetes can have a major effect on people's lives, with just under half (44%) of type 2 patients reporting that the condition has impacted on either their ability or their desire to have sex. The study was conducted online amongst 2,000 patients with type 2 diabetes living in the US, UK and Germany and investigated patients' attitudes, feelings, health status, drug treatment programmes and needs for coping with life with diabetes.

July 28th, 2009 LONDON - The Work Foundation welcomes the "Future Jobs Fund" announced today by the government, but stresses that more needs to be done to help improve opportunities for 16-24 year olds. Commenting on the scheme, Ian Brinkley, Associate Director at The Work Foundation, said: "This is a good start.

June 25th, 2009 LUCERNE, Switzerland - Switzerland's most popular museum currently attracts more than 820,000 visitors a year and is celebrating its 50th anniversary. With the "VHS 2009" investment project covering approximately 50 million Swiss francs, the management of the Swiss Museum of Transport launched and completed what might well be a record-breaking new building and attraction-enhancing programme with a long-term impact on both the premises and content of the museum.

June 23rd, 2009 MUMBAI, India - Release Highlights - Melogliptin continues to demonstrate potential to be the best-in-class in achieving glycemic control with low incidence of hypoglycemia and neutral effect on body weight - Global Phase III trials likely to start by end 2009 - IND approved by USFDA - Glenmark takes a step closer towards becoming the first Indian company to have a truly global innovative drug for the world In the recently completed 12 week Phase IIb clinical trial in 494 patients with type 2 diabetes mellitus (T2DM), 'Melogliptin', Glenmark's investigational medicine from a new class of diabetes treatments called dipeptidyl peptidase 4 (DPP-4) inhibitors, improved glycemic control in patients with type 2 diabetes mellitus and exhibited excellent safety and tolerability profile. In addition, patients taking Melogliptin experienced low incidence of hypoglycemia and neutral effect on body weight.

June 23rd, 2009 SYDNEY and AUCKLAND, New Zealand - Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that the New Zealand Minister of Health, the Honourable Tony Ryall, has authorized LCT's New Zealand Phase I/IIa clinical trial of DIABECELL(R) for insulin dependent diabetes. The authorization confirms the conditions announced on 19 June 2009.

June 4th, 2009 NEW ORLEANS - What Live Webcast: Delivering real patient benefit: Update on new clinical excellence & future company vision Live from the American Diabetes Association 69th Scientific Session When Sunday, June 7th, 2009 10:30am - 11:30am CDT (Central Daylight Time) New Orleans, Louisiana, USA 17:30pm - 18:30pm CEST (Central European Summer Time) Paris, France How to register www.videonewswire.com/event.asp?id=59340 Password: sa2009ADA Highlights This webcast event will feature breaking news from real-life and clinical studies on progress in glycemic control, medication safety, cost-effectiveness, patient well-being and satisfaction. In addition, an update on the sanofi-aventis vision and strategy will further demonstrate the company's commitment to becoming a partner in diabetes healthcare.

May 27th, 2009 LYONS, France - Poxel SAS is Set up in Lyons - France Poxel is a research integrated pharmaceutical Company (RIPCO), spun out from Merck Serono a division of Merck KGaA, Germany, following the decision of Merck Serono to no longer invest in diabetes research and development. It aims to advance promising assets for cardio-metabolic diseases (with a primary focus on Type 2 diabetes) from Research to Phase 2 Clinical Proof-of-Concept, before out-licensing these projects to major pharmaceutical companies.

May 4th, 2009 FELTHAM, England - Innovative Powder Formulation of Metformin Designed to Facilitate Adherence by Increasing Patient Choice in the Treatment of Type 2 Diabetes, Now Available in France and the United Kingdom Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Glucophage(R) Powder for Oral Solution in Sachets, (metformin hydrochloride in 500mg, 850mg and 1000mg strengths) indicated for the first-line treatment of type 2 diabetes mellitus, is now licensed in France and the United Kingdom(1), the first European countries to launch this new formulation of Glucophage(R). Launches in other European countries are expected to take place in the coming months, once individual marketing authorisations are granted.

March 23rd, 2009 LONDON - For the first time ever, experts in bariatric surgery gave a lecture on how weight loss surgery for morbidly obese patients can cure type 2 diabetes, at the Diabetes UK Annual Professional Conference in Glasgow. 'The changing face of diabetes', was the theme for the 2009 conference, introducing the new developments in bariatric research and clinical practice for the future.

March 18th, 2009 WESTLAKE VILLAGE, California - On the cusp of its sophomore season at retail in the performance running category, iconic performance footwear and sportswear brand K-Swiss is proud to announce that it has inked a long-term, official partnership with World Triathlon Corporation, owners of the brand Ironman. Under the agreement, K-Swiss will be the exclusive footwear and apparel provider of an evolving collection of co-branded K-Swiss/Ironman performance and lifestyle footwear and apparel.

January 15th, 2009 WASHINGTON - People with chronic obstructive pulmonary disease (COPD) are nearly twice as likely to be depressed as diabetics. Dutch researchers compared the health characteristics of 999 patients with COPD, 978 patients with diabetes, and 2,494 healthy control subjects.

April 2nd, 2009 MUMBAI - GourmetCITY, the luxury, food and grocery shopping format from HyperCITY Retail (India) Ltd, has been awarded the Coca Cola Golden Spoon "Most admired food retailer of the year - Innovative retail concept" award at the Food Forum of India, 2009 held in Mumbai. Golden Spoon Awards is one of the most eagerly anticipated awards of the food industry.

April 18th, 2009 NEW DELHI - With an Oscar statuette under her belt, Hollywood is at Halle Berry's feet. However, life has never been a bed of roses for this brilliant actress, as she has had to battle one of the world's most common illnesses - diabetes.

September 22nd, 2009 Measure would encourage innovations for the illWASHINGTON — The Senate Finance Committee has adopted the first amendment to a sweeping health overhaul bill, agreeing to a measure to encourage innovative care for hospitalized Medicare patients. Approval of the amendment by Democratic Senator Kent Conrad of North Dakota came late Tuesday as Democrats struggled to push forward on the first day of debate on the legislation.

May 23rd, 2009 BANGALORE - Mechanical Engineering students of a Bangalore college have developed a compressible car, which can be of great help to those who are faced with parking or traffic problem. The car named LARSA (Linearly Actuated Retractable Sedan Type Automobile) has been designed by final year mechanical engineering students of the MS Ramaiah Institute of Technology.

April 14th, 2009 HYDERABAD - After the successful launch of Mid-Day Market scan and sms alerts on all BSE NSE stocks, Vantagetrade has come up with a unique concept in stock trading. Interday Trend Calls is a unique trading concept, where the daily price movement can be monetized thus maximizing the gain.

June 14th, 2009 WASHINGTON - A new study has shown that post-meal surges in blood sugar can cut a man's level of circulating testosterone by about a quarter. According to study's researchers, the finding might help doctors decide to test for testosterone levels while patients are fasting.

September 25th, 2009 BIHTA - Lok Sabha Speaker Meira Kumar on Friday laid the foundation stone for a hospital in here, about 40 kilometers from Patna, capital of Bihar. Chief Minister Nitish Kumar was present on the occasion.

September 25th, 2009 WASHINGTON - A childhood kidney disorder, which was believed to disappear after puberty, is likely to persist into adulthood and cause significant long-term complications, reveals a new study. The study's researchers suggest that better treatment options are needed for children with the disorder, called minimal change nephrotic syndrome.

June 25th, 2009 NEW DELHI - Touch Bionics, Scottish developer of the world's first commercially available bionic hand, today announced its market entry into India. The company's Indian distributor, Innovative Prosthetics and Orthotics Pvt Ltd., officially launched the i-LIMB Hand, the world's most advanced upper limb prosthetic device, in India today.